Breast Cancer Segment to Drive Radiotherapy Market

According to our new research study on “Radiotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type, Product, Application, and End User,” the market is expected to reach US$ 10,170.80 million by 2028 from US$ 6,474.78 million in 2020; it is estimated to grow at a CAGR of 5.9% from 2021 to 2028. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The growth of the market is attributed to a few key driving factors such as increasing prevalence of cancer and rising number of conferences and symposiums to boost the awareness about radiation therapy. However, the increased risk of adverse effects due to radiation therapy restrains the market growth.

Radiotherapy is majorly used to control the growth of a tumor while restricting the harm to nearby normal and healthy tissue. Radiotherapy uses high-energy radiation, generally x-rays, to destroy the cancer cells and treat tumors in the prostate, breast, head & neck, lung, and any other parts in the body where radiation treatment is indicated.

Based on application, the radiotherapy market is segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, cervical cancer, liver cancer, thyroid cancer, lymphoma, spine cancer, brain cancer, and others. In 2020, the breast cancer segment held the largest share of the market. However, the lung cancer segment is estimated to register the highest CAGR of 7.5% during the forecast period.

The radiotherapy market is expected to witness substantial growth after the COVID-19 pandemic. Delayed or rescheduled radiation therapy treatments and new cancer cases are anticipated to have positive impact on the market growth post-pandemic.

Siemens Healthineers AG, Accuray Incorporated, Sumitomo Heavy Industries, Ltd., Elekta AB, Hitachi, Ltd., Koninklijke Philips N.V., Brainlab AG, PROTOM INTERNATIONAL, Varian Medical Systems, Inc., Maastro, and Mevion Medical Systems are among the leading companies operating in the radiotherapy market.

The report segments radiotherapy market as follows:

By Type

• External-Beam Radiation Therapy

• Internal Radiation Therapy

• Systemic Radiotherapy/Radiopharmaceuticals

By Product

• External Beam Radiotherapy Products

• Internal Radiotherapy Products

• Radiotherapy Software

• Others

By Application

• Breast Cancer

• Lung Cancer

• Colorectal Cancer 

• Prostate Cancer

• Cervical Cancer

• Liver Cancer

• Thyroid Cancer

• Lymphoma

• Spine Cancer

• Brain Cancer

• Others 

By End User

• Hospitals

• Specialty Clinics

• Radiation Therapy Centers

By Geography

• North America

 US

 Canada

 Mexico

• Europe

 France

 Germany

 UK

 Spain

 Italy

 Rest of Europe

• Asia Pacific (APAC)

 China

 India

 Japan

 Australia

 South Korea

 Rest of APAC

• Middle East & Africa (MEA)

 Saudi Arabia

 UAE

 South Africa

 Rest of MEA

• South and Central America (SCAM)

 Brazil

 Argentina

 Rest of SCAM 

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com